Description

Description

Inosita 50mg is a prescription tablet manufactured by PharmEvo, formulated with Sitagliptin as its active ingredient. It belongs to a class of oral anti-diabetic medicines known as DPP-4 inhibitors, which work by supporting the body’s own natural mechanisms for regulating blood sugar rather than forcing insulin release directly. This tablet is intended for adults living with type 2 diabetes mellitus and is often prescribed as part of a broader treatment plan that includes diet, exercise, and, in many cases, other glucose-lowering medicines. Each pack contains 28 tablets, providing roughly a month’s supply for patients following a once-daily dosing routine.

Ingredients

Each film-coated tablet of Inosita 50mg contains 50 milligrams of Sitagliptin, present in its phosphate monohydrate form, as the sole active pharmaceutical ingredient. The tablet’s film coating helps make it easier to swallow and protects the active compound as it moves through the stomach before being absorbed into the bloodstream. In addition to the active ingredient, the tablet contains standard inactive components such as fillers, binders, and coating agents, which serve only to maintain the tablet’s shape, consistency, and shelf stability.

Dosage Form

Inosita 50mg is available as an oral, film-coated tablet meant for once-daily use. As a solid oral dosage form, it should be swallowed whole and should not be crushed, chewed, or split, since doing so may affect how consistently the medicine is released and absorbed in the body.

Uses

Inosita 50mg is used to help manage blood glucose levels in adults with type 2 diabetes mellitus. By inhibiting the DPP-4 enzyme, it increases the levels of certain natural hormones in the body that prompt the pancreas to release insulin when blood sugar is high and reduce the release of glucagon, a hormone that raises blood sugar. This glucose-dependent action means the medicine works mainly when blood sugar is elevated, which helps support balanced glycemic control. It is commonly prescribed alongside lifestyle changes such as a controlled diet and regular physical activity, and it may also be combined with other oral diabetes medicines when a single treatment is not enough to keep blood sugar within target range.

How to Use

Inosita 50mg is typically taken once daily, with or without food, exactly as instructed by the prescribing doctor. Taking the tablet at the same time each day helps build a consistent routine and supports more stable blood sugar control over time. The tablet should be swallowed whole with a glass of water. Patients should not change their dose or stop taking the medicine without first speaking to their doctor, since diabetes management usually depends on steady, uninterrupted treatment combined with regular blood sugar monitoring. Routine check-ups and periodic laboratory tests are often recommended so the doctor can assess how well the treatment is working and adjust the plan if necessary.

Side Effects

Inosita is generally well tolerated, though some patients may experience side effects. Commonly reported effects include mild nausea, headache, or upper abdominal discomfort. Some individuals may notice drowsiness or mild diarrhea. Because this medicine can be used alongside other diabetes treatments, there is a possibility of low blood sugar (hypoglycemia) when combined with certain other medications, so patients should be aware of symptoms such as shakiness, sweating, or dizziness. In rare cases, more serious reactions such as pancreatitis, severe allergic responses, or joint pain have been reported, and any unusual or persistent symptoms should be brought to a doctor’s attention promptly.

Pregnancy & Breastfeeding

There is limited established data on the safety of Sitagliptin during pregnancy or breastfeeding. Because of this, Inosita 50mg should only be used during pregnancy or while breastfeeding if a doctor determines that the potential benefit justifies any possible risk. Women who are pregnant, planning to become pregnant, or currently breastfeeding should discuss their diabetes management options with their healthcare provider before starting or continuing this medication.

Storage Instructions

Inosita tablets should be stored at room temperature, generally below 30°C, in a dry location away from direct sunlight, heat, and moisture. Keeping the tablets in their original packaging until they are needed helps protect them from humidity. The medicine should be kept out of the reach of children and pets, and any expired or unused tablets should be disposed of properly rather than kept beyond their intended shelf life.

FAQs

Can Inosita 50mg be used alone, or does it need to be combined with other medicines?
It can be prescribed on its own or alongside other oral diabetes medications, depending on how well a patient’s blood sugar is controlled and what their doctor recommends.

Does Inosita cause low blood sugar on its own?
When used by itself, Inosita has a relatively low risk of causing hypoglycemia because its action is glucose-dependent, though the risk can increase when combined with certain other diabetes medicines.

Is Inosita suitable for type 1 diabetes?
No, this medicine is intended specifically for type 2 diabetes mellitus and is not appropriate for managing type 1 diabetes.

How long does it take for Inosita to start working?
Sitagliptin begins acting on blood sugar levels fairly quickly after each dose, but noticeable improvements in overall glucose control are usually assessed over several weeks of consistent use.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.